NCT01908803View on ClinicalTrials.gov

Proof-of-Concept Study of a Single Application of an Investigational Otic Suspension in Treatment of Acute Otitis Media With Tympanostomy Tubes

PHASE2TerminatedINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

August 31, 2014

Study Completion Date

August 31, 2014

Conditions
Acute Otitis Media
Interventions
DRUG

AL-60371/AL-817 otic suspension

DRUG

Ciprofloxacin 0.3%/dexamethasone 0.1% otic suspension

CIPRODEX®

Sponsors

Lead Sponsor

Alcon Research
All Listed Sponsors
lead

Alcon Research

INDUSTRY

NCT01908803 - Proof-of-Concept Study of a Single Application of an Investigational Otic Suspension in Treatment of Acute Otitis Media With Tympanostomy Tubes | Biotech Hunter | Biotech Hunter